Independent, AI-assisted research · Affiliate disclosure
TRT Atlas

Subcutaneous vs Intramuscular Testosterone Injections: Which Is Better?

Subcutaneous vs intramuscular testosterone injections compared: effectiveness, blood level stability, side effects, hematocrit, pain, and which to choose.

If you inject testosterone, you have a choice most people never think about. You can push the oil deep into a muscle. Or you can put it in the fat layer just under your skin. Same drug. Same dose, in many cases. Two very different needles, and two slightly different experiences.

For decades, every doctor said the same thing: testosterone goes in the muscle. That's how the labels were written. That's how nurses were trained. Then the research caught up, and a quieter option moved into the mainstream. The subcutaneous (SubQ or SC) shot turned out to work about as well as the deep muscle (IM) shot for most men, with a smaller needle and less drama.

So which one should you use? Here's the honest answer up front, then the evidence behind it.

Medical disclaimer: This guide is for education, not medical advice. Testosterone is a controlled substance (Schedule III in the U.S.). Injection route, dose, and monitoring must be decided with a licensed prescriber. Never start, stop, or change your protocol based on an article.

Quick Answer

  • Both routes work. Subcutaneous and intramuscular injections deliver similar total testosterone over a week; for most men, blood levels land in the same range (J Clin Endocrinol Metab, 2022).
  • SubQ is easier and usually less painful. A small insulin needle in the belly fat hurts less and is simpler to self-inject than a deep shot in the glute (Am J Health Syst Pharm, 2018).
  • IM may peak higher and faster. Muscle absorbs the oil quicker, which can mean a bigger early spike and a lower trough between shots.
  • Pick with your prescriber. Route depends on your dose, your comfort, your hematocrit, and whether you're using a vial or an FDA-approved auto-injector like Xyosted.

What's the Difference Between Subcutaneous and Intramuscular Injections?

The difference is depth. Nothing more, nothing less.

An intramuscular (IM) injection goes through the skin and fat and into the muscle below. Common sites are the gluteus (upper outer butt cheek), the thigh (vastus lateralis), and the shoulder (deltoid) for small doses. Muscle has a rich blood supply, so it pulls the testosterone oil into circulation fairly fast. IM is the route written on most older testosterone vial labels.

A subcutaneous (SubQ or SC) injection stops short, landing in the layer of fat between skin and muscle. The belly and the front of the thigh are the usual spots. Fat has fewer blood vessels, so it releases the oil more slowly and steadily. This is the same layer where people inject insulin, GLP-1 drugs, and many fertility medications.

Testosterone esters used for injection are dissolved in oil. The two most common are testosterone cypionate and testosterone enanthate. The ester controls how slowly the hormone releases once it's in your body. Both esters can be given IM or SubQ.

Side-by-side: the core differences

FeatureSubcutaneous (SubQ)Intramuscular (IM)
Where it goesFat under the skinInside the muscle
Typical sitesAbdomen, front of thighGlute, thigh, shoulder
Needle gauge25–29G (thinner)22–25G (thicker)
Needle length1/2–5/8 inch1–1.5 inch
Pain levelUsually mildModerate; deeper
Absorption speedSlower, steadierFaster, bigger early peak
Self-injectionEasierHarder to reach glute
FDA-approved auto-injectorYes (Xyosted)No dedicated SC-free product

The takeaway: the drug is the same. The route changes how it feels going in and how the oil trickles into your blood afterward.

Does Subcutaneous Testosterone Work as Well as Intramuscular?

Yes, for most men. This is the question that matters most, and the research is reassuring.

A 2022 review in the Journal of Clinical Endocrinology & Metabolism looked at the full body of evidence and concluded that subcutaneous testosterone is "a safe, practical, and reasonable option" (J Clin Endocrinol Metab, 2022). The authors found that the total amount of testosterone delivered over a week, measured as area under the curve, was similar between weekly SubQ and standard IM dosing.

A 2022 study in the Journal of Urology compared hypogonadal men on IM testosterone cypionate against men on SubQ testosterone enanthate (J Urol, 2022). Both groups reached normal testosterone levels. The route did not stop the therapy from working.

Earlier proof came from a 2018 crossover study. Researchers took 14 people on stable IM testosterone, kept them on IM for three weeks, then switched them to SubQ for eight weeks (Am J Health Syst Pharm, 2018). The subcutaneous route "was well tolerated and appeared to be as effective as intramuscular injection in delivering equivalent testosterone levels." The catch, the authors noted, was wide variability from person to person. Some people absorbed it slightly differently.

The biggest real-world proof is FDA approval. Xyosted is a subcutaneous testosterone enanthate auto-injector. In its trial, 135 of 150 hypogonadal men (90%) had a total testosterone in the normal range (300–1100 ng/dL) at week 12 (FDA label, 2025). The U.S. government would not approve a subcutaneous testosterone product that didn't raise levels reliably.

What "works as well" actually means

OutcomeEvidenceSource
Reaches normal T range90% in range at week 12 (Xyosted)FDA label, 2025
Total weekly testosterone (AUC)Similar SubQ vs IMJ Clin Endocrinol Metab, 2022
Symptom reliefComparable in studiesJ Urol, 2022
Person-to-person variabilityWider with SubQAm J Health Syst Pharm, 2018

If your blood work comes back in range and your symptoms improve, the route did its job. For most men, SubQ does that.

Is Subcutaneous or Intramuscular Better for Blood Level Stability?

This is where the two routes start to separate. Stability is the second-biggest reason people switch.

Muscle has more blood flow than fat. So an IM shot tends to release testosterone faster. You get a higher early peak, sometimes within 24 to 48 hours, then a longer slide down to a lower trough before your next dose. With weekly IM dosing, some men feel that swing. Great energy a couple days after the shot, then a flat, irritable stretch near the end of the week.

SubQ releases the oil more slowly because fat is a slower depot. The peaks are gentler and the troughs are higher. Many patients describe SubQ as "smoother." The research supports the lived experience: the subcutaneous depot blunts the sharp peak-to-trough swing that some men get with IM.

Two practical notes:

  • Frequency matters more than route. Splitting your weekly dose into two smaller injections flattens the curve no matter which route you pick. A man doing twice-weekly SubQ will be steadier than a man doing one big IM shot, and a man doing twice-weekly IM will be steadier than a man doing one big SubQ shot.
  • Esters behave the same either way. Cypionate and enanthate have nearly identical release timing. Switching esters won't fix a swing; changing frequency will.

If chasing stable levels is your goal, the combination most men land on is smaller, more frequent SubQ doses. For the bigger picture on how route fits into the whole TRT toolkit, see our guide on TRT delivery methods: injections vs cream vs pellets vs nasal.

Which Route Causes Fewer Side Effects?

Both routes share testosterone's side effects, because it's the same hormone. But the route changes a few things at the margins, and one difference may matter for your blood.

Hematocrit and erythrocytosis

The most common reason TRT gets paused is a high hematocrit, the percentage of your blood made up of red cells. Testosterone tells your body to make more red blood cells. Too many, and your blood thickens. Doctors call this erythrocytosis, and it raises the risk of clots.

Here's the interesting part. Some data suggest the slower, steadier SubQ absorption may push hematocrit up less than the sharper IM peaks. One subcutaneous cypionate study reported a new-onset erythrocytosis rate lower than rates commonly published for IM injections (J Clin Endocrinol Metab, 2022). In the 52-week subcutaneous enanthate (Xyosted) study, a high hematocrit was reported as an adverse reaction in 21 of 150 men (14%) (FDA label, 2025).

This isn't settled science. A network meta-analysis found that all injectable testosterone raises hematocrit, and the big driver is the dose and the peak, not just the route. Still, if your hematocrit runs high on IM, switching to SubQ with a split dose is a reasonable thing to discuss with your prescriber. Either way, you need regular labs. Our TRT blood work and monitoring guide walks through exactly what to track and how often.

Estradiol and aromatization

Testosterone converts to estradiol (estrogen) through an enzyme called aromatase. A few clinicians argue that lower peaks from SubQ mean less estradiol spiking. The evidence is thin and mixed. Don't pick a route to control estrogen. If estrogen is your concern, read our breakdown of estrogen management on TRT and the anastrozole debate first, because the answer is usually "leave it alone and dose correctly," not "change your needle."

Injection site reactions

SubQ has one downside: lumps. Because the oil sits in fat, some men get small nodules, redness, or itching at the site. In the 52-week subcutaneous enanthate trial, reactions included erythema (redness), induration (firmness), and small bruises, but they were mostly mild and faded. Rotating sites helps. IM injections can also bruise or get sore, and a deep glute shot can occasionally hit a nerve if your aim is off, which is rare but real.

The blood pressure warning applies to both

The FDA put a boxed warning on Xyosted, the subcutaneous product, for blood pressure. In trials it raised systolic blood pressure by an average of about 4 mmHg, and 10% of treated men needed new or adjusted blood pressure medication over a year (FDA label, 2025). This is a testosterone effect, not a SubQ effect. The same caution applies to IM. Get your blood pressure checked. For the full safety picture across all of TRT, see TRT side effects and safety: what the evidence says.

Side effectSubQIM
High hematocritPossibly lower (slower peaks)Possibly higher
Injection painUsually mildModerate to higher
Site lumps/nodulesMore commonLess common
BruisingPossible, smallPossible, deeper
Blood pressure riseYes (drug effect)Yes (drug effect)
Estradiol swingsPossibly smootherPossibly sharper

How Do You Inject Testosterone Subcutaneously?

SubQ is the route most people can learn in one session. The needle is small and the target is forgiving. Still, get hands-on training from your clinic before you do this alone. The Endocrine Society and AUA both stress proper instruction (Endocrine Society, 2018; AUA Guideline, 2018).

The general technique used in the research:

  1. Draw with one needle, inject with another. Testosterone oil is thick. Use a slightly larger needle (like a 23–25G) to draw from the vial, then swap to a smaller needle (25–29G, 1/2 inch) for the actual injection. This keeps the injection needle sharp and the shot painless.
  2. Pick a fatty site. The belly, about 3 to 5 cm to the side of your navel, or the front of your thigh. Skip the 2-inch zone right around the navel.
  3. Pinch and angle. Pinch a fold of fat. Insert at 45 to 90 degrees depending on how much fat you have. The needle is short, so it won't reach muscle.
  4. Push slow. Smaller doses sting less. Slow pressure spreads the oil and reduces lumps.
  5. Rotate. Don't hit the same spot every week. Rotating sides and sites prevents nodules and scar tissue.

Studies typically used 1 mL Luer-Lok syringes with 25-gauge 5/8-inch needles for SubQ testosterone, injecting into the abdomen or thigh (J Clin Endocrinol Metab, 2022). A Luer-Lok (twist-on) syringe is preferred over a slip-tip because thick oil can pop a slip-tip needle off mid-injection.

If you're prescribed Xyosted, none of this applies. It's a pre-filled, pre-set auto-injector. You press it against your belly and it does the work, once a week, in the abdomen only (FDA label, 2025).

Needle quick reference

JobGaugeLength
Drawing oil from vial21–25G1–1.5 inch
SubQ injection25–29G1/2–5/8 inch
IM injection (glute/thigh)22–25G1–1.5 inch
IM injection (delta/small dose)23–25G5/8–1 inch

What Are the Pros and Cons of Each Route?

Here's the trade-off in plain terms.

Subcutaneous testosterone — pros:

  • Smaller needle, less pain
  • Easier to self-inject (you can see your own belly)
  • Slower, steadier absorption with fewer peak-and-crash swings
  • Possibly lower hematocrit rise
  • An FDA-approved auto-injector exists (Xyosted)

Subcutaneous testosterone — cons:

  • Can cause small lumps or nodules in the fat
  • Slightly more person-to-person variability in absorption
  • Some older vial labels technically only list IM use (off-label, though widely accepted)

Intramuscular testosterone — pros:

  • Long, proven track record; it's the original FDA route
  • Very reliable absorption
  • Larger volume tolerated in one shot for high doses

Intramuscular testosterone — cons:

  • Bigger needle, more pain
  • Harder to self-administer in the glute
  • Sharper peak-to-trough swings on weekly dosing
  • Possibly higher hematocrit rise

For most men starting TRT today, clinics lean SubQ because it's gentler and adherence is better. People stick with a shot that doesn't hurt. The 2022 review put it plainly: clinicians should discuss SubQ "because it is easier to self-administer and has the potential to improve patient adherence" (J Clin Endocrinol Metab, 2022).

Which One Should You Choose?

There's no universal winner. There's a winner for you. Use this to frame the conversation with your prescriber.

If you...Lean toward
Hate needles or fear injectingSubQ (thinner needle)
Get peak-and-crash mood swingsSubQ with split dosing
Have a high or rising hematocritSubQ, split dose, discuss with doctor
Want an FDA auto-injectorSubQ (Xyosted)
Get persistent lumps on SubQIM
Need a large single doseIM
Already do IM and feel greatDon't fix what isn't broken

A few honest realities. First, your dose and frequency matter more than your route for how you feel. A bad protocol on the "better" route beats nobody. Second, cost can drive the choice: a vial of cypionate you inject yourself is cheap, while a branded auto-injector like Xyosted runs much more. Run the numbers with our TRT cost calculator and compare full pricing in how much does TRT cost. Third, the right provider will offer you a choice and explain the trade-offs instead of defaulting to whatever they always do. If yours won't, our guide on how to choose a TRT provider and our provider directory can help you find one who will.

Still deciding whether injections are even right for you, versus creams or pellets? Our side-by-side comparison hub lays out every delivery method against each other.

Frequently Asked Questions

Is subcutaneous testosterone as effective as intramuscular?

For most men, yes. Studies show both routes deliver similar total testosterone over a week and reach normal blood levels (J Clin Endocrinol Metab, 2022). In the Xyosted trial, 90% of men hit the normal range by week 12 (FDA label, 2025). There's slightly more person-to-person variation with SubQ, so your labs guide any fine-tuning.

Does subcutaneous testosterone cause less estrogen than intramuscular?

Maybe a little, but the evidence is weak and mixed. The theory is that SubQ's lower peaks mean less conversion to estradiol. Don't choose your route to manage estrogen. Dose correctly and check labs instead. Read estrogen management on TRT before reaching for an aromatase inhibitor.

Does subcutaneous testosterone raise hematocrit less than IM?

Some studies suggest the slower SubQ absorption may raise hematocrit less than the sharp IM peaks, but all injectable testosterone can thicken your blood. The bigger factors are your dose and how high your peaks run. Regular blood work is non-negotiable on either route; see our TRT monitoring guide.

Can I switch from intramuscular to subcutaneous without changing my dose?

Often yes, but only with your prescriber's sign-off. Because total absorption is similar, many men keep the same weekly milligram dose and just change the needle and site. Some need a small adjustment based on follow-up labs. Don't switch on your own. The route change can shift your peaks and troughs.

Which needle size is best for subcutaneous testosterone?

Most men use a 25 to 29 gauge needle, 1/2 to 5/8 inch long, on a 1 mL Luer-Lok syringe, injecting into the belly or thigh (J Clin Endocrinol Metab, 2022). Draw the thick oil with a slightly larger needle, then swap to the thin one to inject. Always get hands-on training from your clinic first.

Related Reading

Sources

  • Figueiredo MG, Gagliano-Jucá T, Basaria S. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option. J Clin Endocrinol Metab, 2022. PMC9006970
  • Wilson DM, Kiang TKL, Ensom MHH. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study. Am J Health Syst Pharm, 2018. PMID 29367424
  • Choi EJ, et al. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate. J Urol, 2022. PMID 34694927
  • Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018. PMID 29562364
  • Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol, 2018. PMID 29601923
  • XYOSTED (testosterone enanthate) injection, for subcutaneous use — Prescribing Information. U.S. FDA, 2025. FDA label

-- The TRT Atlas Team

Compare providers

Ready to act on this? Compare TRT providers side by side on cost, what's included, and fertility options — or estimate your true monthly cost.

Related guides

Educational information, not medical advice. Testosterone-therapy decisions should be made with a qualified physician. Figures are typical ranges, not prescriptions.